COMP <GO>
ISRG vs MRK // RETURN ON INVESTED CAPITAL (ROIC)
Intuitive Surgical Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: ISRG 5
— MRK 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MRK
LAST: $432.01 (-3.73%) • MKT CAP: $155.56B
roic
15.00%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
roic
20.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ISRG VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ISRG | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.00% | 74.80% | -8.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 15.00% | 20.70% | -5.70 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 46.0x | 15.3x | +30.70 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 1.66% | 3.42% | -1.76 | MRK | /fcf-yield <GO> |
| Operating Margin | 29.30% | 34.30% | -5.00 | MRK | /operating-margins <GO> |
| Net Profit Margin | 28.40% | 28.10% | +0.30 | ISRG | /net-margins <GO> |
| Revenue Growth (YoY) | 20.50% | 1.30% | +19.20 | ISRG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.19 | +20.81 | ISRG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | ISRG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.60% | +0.20 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.1 | 56.9 | -2.71 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 0.92 | +0.05 | ISRG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 45.8x | 18.4x | +27.40 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $155.56B | $361.02B | -$205.46B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ISRG REV | MRK REV | ISRG GROSS % | MRK GROSS % | ISRG FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.06B | $65.01B | 66.0% | 74.8% | $2.58B | $12.36B |
| FY 2024 | $8.35B | $64.17B | 67.5% | 76.3% | $2.04B | $18.10B |
| FY 2023 | $7.12B | $60.12B | 44.0% | 44.0% | $1.49B | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ISRG // BETA 0.97
MRK // BETA 0.92